
aman kumar
303 posts

aman kumar
@amaniable
You may say I'm a dreamer ! but I'm not the only one . . .







#AxiscadesTech | #AzadTech | #ManoramaIndustries Looking at all 3 businesses, there is a strong possibility of each scaling toward a Rs 50,000 Cr Market cap over time. But to truly understand this potential, one needs to go beyond surface-level numbers and deeply study the businesses. These are high-quality, deep-tech driven companies with strong structural growth tailwinds. In such businesses, management quality plays a critical role they are the ones who allocate capital, execute strategy, and ultimately drive long-term value creation. A few key investing principles: Invest in the story, stay invested in numbers: The narrative gives direction, but execution reflects in financials over time. Today’s topline is tomorrow’s PAT: Revenue growth, when backed by operating leverage and discipline, translates into profitability. The real edge lies in combining business understanding with patience.






Q2FY26 pessimism rate of change tracker , pessimism themes that have sharply faced major profit pool collapses , Valuation multiple collapses and Increased capacity problems ( over last 2Y) 1) Chemicals 2) PVC pipes 3) Plywood , Laminates 4) Microfinance Now what is my approach here in Q2 ? See where rate of change is visible from a base structure , MFI can stabilize with base building for earnings , with rate of change in earnings from Q3 , Armaan , Northern Arc commentary is Key here PVC pipes - Expecting weak quarter due to delayed monsoons and pvc prices sustaining lower , need to see some pricing support and atleast a reduction in rate of fall of prices , yet to reach base building Plywood , Laminates - Will be listening to Greenlam commentary and Stylam , want to see how their new products and TAM is building as far as home improvement Chemicals- Maybe another base building quarter here ,Deepak may see some small margin benefits from WNA plant and some integrations , Aarti will listen to commentary , want to see what Camlin says about vanillin , Clean science has been buzzing with interesting deals happened recently so will look again and Jubilant ingrevia we will look on the pipeline for FY27 This is the approach for the pessimism themes here , MFI>Chemicals>Plywood>PVC pipes , this is where I will put more bandwidth This is the research we are doing without ownership in most names above , just to spot rate of change in this , hope you find it useful , updates will come as earnings start to come through , and also these are the less effort pessimism themes , lots of more notes on fresh themes , positive rate of change coming .. We may or may not buy as we see rate of change , but this is the level of prep we are walking into these pessimistic themes This is apart from our core coverage universe that I am tracking , core will be more in detail , hope you all finding it useful to keep sectoral knowledge in tough times @ishmohit1 @EquityInsightss













I recently had dinner with Dr Devi Shetty, the founder of Narayana Hospitals. For those who don't know him, he's the guy who figured out how to do open heart surgery for a few hundred dollars when the same procedure costs a bomb in the US. Narayana has 18,000 beds across India, and if you ask most middle-class people in Bangalore about it, they'll speak highly of it. There was one thing I kept thinking about over and over again after meeting him. Narayana's market cap is around ₹38,000 crore. Now compare that to pretty much any half-decent financial services business in India, and it'll be valued more than that, including Zerodha. A brokerage, worth more than a hospital chain, that has probably saved hundreds of thousands of lives. I get the arguments. If you're a fund manager/analyst, you can immediately explain it away using margins, capex, asset-light vs asset-heavy, and all that, and I'm not saying the market is wrong. But it's still a strange world we've built, where the businesses closest to money get valued the highest, and the ones doing the hard and essential things get priced like boring utilities. A hospital carries physical infrastructure, enormous liability, thin margins and the actual weight of keeping people alive. And somehow that's worth less than a platform for buying and selling stocks. I don't have a clean take on this. All of this just felt odd. Ps: Nothing here is investment advice. For that, go to @zerodhavarsity






